Alan L. Ho

Active 1998–2025

103
Papers
21,638
Citations
55
h-index
91
i10-index

Citations

Citations per year for Alan L. Ho1976: 1 citations1977: 1 citations1992: 2 citations1998: 2 citations1999: 7 citations2000: 36 citations2001: 78 citations2002: 113 citations2003: 121 citations2004: 101 citations2005: 88 citations2006: 69 citations2007: 66 citations2008: 59 citations2009: 62 citations2010: 51 citations2011: 63 citations2012: 56 citations2013: 79 citations2014: 87 citations2015: 67 citations2016: 76 citations2017: 109 citations2018: 138 citations2019: 685 citations2020: 977 citations2021: 1,131 citations2022: 1,018 citations2023: 823 citations2024: 1,199 citations2025: 548 citations2026: 19 citations1978–1991: no citations, so these years are not shown1993–1997: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 3,319 citing papers, 30% of this breakdownChina: 1,515 citing papers, 13.7% of this breakdownGermany: 549 citing papers, 5% of this breakdownItaly: 531 citing papers, 4.8% of this breakdownUnited Kingdom: 512 citing papers, 4.6% of this breakdownFrance: 412 citing papers, 3.7% of this breakdownCanada: 385 citing papers, 3.5% of this breakdownJapan: 377 citing papers, 3.4% of this breakdownSpain: 321 citing papers, 2.9% of this breakdownNetherlands: 291 citing papers, 2.6% of this breakdownAustralia: 244 citing papers, 2.2% of this breakdownSwitzerland: 227 citing papers, 2% of this breakdown
0%30%Other 21.6%

Fields

  • Medicine59.5%
  • Biochemistry, Genetics and Molecular Biology32.4%
  • Immunology and Microbiology3.8%
  • Neuroscience1.2%
  • Computer Science0.9%
  • Materials Science0.5%
  • Other1.7%

Topics

  • Cancer Immunotherapy and Biomarkers7.4%
  • Cancer Genomics and Diagnostics5.7%
  • Lung Cancer Treatments and Mutations3.1%
  • Immunotherapy and Immune Responses2.9%
  • RNA Interference and Gene Delivery2.8%
  • Ferroptosis and cancer prognosis2.4%
  • Other75.7%

Coauthors

All papers

Open in search
  1. Tumor mutational load predicts survival after immunotherapy across multiple cancer types

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Philip H. Gutin, Cameron Brennan, Viviane Tabar, Ingo K. Mellinghoff, Lisa M. DeAngelis, Charlotte E. Ariyan, Nancy Y. Lee, William D. Tap, Mrinal M. Gounder, Sandra P. D’Angelo, Leonard B. Saltz, Zsofia K. Stadler, Howard I. Scher, José Baselga, Pedram Razavi, Christopher A. Klebanoff, Rona Yaeger, Neil H. Segal, Geoffrey Y. Ku, Ronald P. DeMatteo, Marc Ladanyi, Naiyer A. Rizvi, Michael F. Berger, Nadeem Riaz, David B. Solit, Timothy A. Chan, Luc G.T. Morris - Nature Genetics 2019 cited by 4,358

  2. OncoKB: A Precision Oncology Knowledge Base

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Antonio Omuro, Michael A. Postow, Dana E. Rathkopf, Alexander N. Shoushtari, Neerav Shukla, Martin H. Voss, Ederlinda Paraiso, Ahmet Zehir, Michael F. Berger, Barry S. Taylor, Leonard B. Saltz, Gregory J. Riely, Marc Ladanyi, David M. Hyman, José Baselga, Paul Sabbatini, David B. Solit, Nikolaus Schultz - JCO Precision Oncology 2017 cited by 2,698

  3. Genomic characterization of metastatic patterns from prospective clinical sequencing of 25,000 patients

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Yelena Y. Janjigian, Michael J. Morris, Robert J. Motzer, Eileen M. O’Reilly, Michael A. Postow, Nitya Raj, Gregory J. Riely, Mark E. Robson, Jonathan E. Rosenberg, Anton Safonov, Alexander N. Shoushtari, William D. Tap, Min Yuen Teo, Anna M. Varghese, Martin H. Voss, Rona Yaeger, Marjorie G. Zauderer, Nadeem R. Abu‐Rustum, Julio García‐Aguilar, Bernard H. Bochner, A. Ari Hakimi, William R. Jarnagin, David R. Jones, Daniela Molena, Luc G.T. Morris, Eric Rios‐Doria, Paul Russo, Samuel Singer, Vivian E. Strong, Debyani Chakravarty, Lora H. Ellenson, Anuradha Gopalan, Jorge S. Reis‐Filho, Britta Weigelt, Marc Ladanyi, Mithat Gönen, Sohrab P. Shah, Joan Massagué, Jianjiong Gao, Ahmet Zehir, Michael F. Berger, David B. Solit, Samuel F. Bakhoum, Francisco Sánchez-Vega, Nikolaus Schultz - Cell 2022 cited by 663

  4. HER2-Mediated Internalization of Cytotoxic Agents in ERBB2 Amplified or Mutant Lung Cancers

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Anuja Bhalkikar, Fabiola Cecchi, David M. Hyman, Jason S. Lewis, Darren J. Buonocore, Alan L. Ho, Vicky Makker, Jorge S. Reis‐Filho, Pedram Razavi, Maria E. Arcila, Mark G. Kris, John T. Poirier, Ronglai Shen, Junji Tsurutani, Gary A. Ulaner, Elisa de Stanchina, Neal Rosen, Charles M. Rudin, Maurizio Scaltriti - Cancer Discovery 2020 cited by 289

  5. Immunogenic neoantigens derived from gene fusions stimulate T cell responses

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Richard J. Wong, Neerav Shukla, Timothy A. Chan, Luc G.T. Morris - Nature Medicine 2019 cited by 382

  6. Randomized Phase II Trial of Nivolumab With Stereotactic Body Radiotherapy Versus Nivolumab Alone in Metastatic Head and Neck Squamous Cell Carcinoma

    Authors: , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2020 cited by 394

  7. Tipifarnib in Head and Neck Squamous Cell Carcinoma WithHRASMutations

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2021 cited by 196

  8. Selumetinib-Enhanced Radioiodine Uptake in Advanced Thyroid Cancer

    Authors: , , , , , , , , , , , , , , , , - New England Journal of Medicine 2013 cited by 829

  9. Genomic characterization of metastatic patterns from prospective clinical sequencing of 25,000 patients

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Michael J. Morris, Robert J. Motzer, Eileen M. O’Reilly, Michael A. Postow, Nitya Raj, Gregory J. Riely, Mark E. Robson, Jonathan E. Rosenberg, Anton Safonov, Alexander N. Shoushtari, William D. Tap, Min Yuen Teo, Anna M. Varghese, Martin H. Voss, Rona Yaeger, Marjorie G. Zauderer, Nadeem R. Abu‐Rustum, Julio García‐Aguilar, Bernard H. Bochner, A. Ari Hakimi, William R. Jarnagin, David R. Jones, Daniela Molena, Luc G.T. Morris, Eric Rios‐Doria, Paul Russo, Samuel Singer, Vivian E. Strong, Debyani Chakravarty, Lora H. Ellenson, Anuradha Gopalan, Jorge S. Reis‐Filho, Britta Weigelt, Marc Ladanyi, Mithat Gönen, Sohrab P. Shah, Joan Massagué, Jianjiong Gao, Ahmet Zehir, Michael F. Berger, David B. Solit, Samuel F. Bakhoum, Francisco Sánchez-Vega, Nikolaus Schultz - 2021 cited by 69

  10. Vemurafenib Redifferentiation of BRAF Mutant, RAI-Refractory Thyroid Cancers

    Authors: , , , , , , , , , , , , , , , , , , , , - The Journal of Clinical Endocrinology & Metabolism 2018 cited by 242

  11. In Vivo Protein Transduction: Delivery of a Biologically Active Protein into the Mouse

    Authors: , , , - Science 1999 cited by 2,433

  12. Phase II Study of Lenvatinib in Patients With Progressive, Recurrent or Metastatic Adenoid Cystic Carcinoma

    Authors: , , , , , , , , , , - Journal of Clinical Oncology 2019 cited by 236

  13. Genetic hallmarks of recurrent/metastatic adenoid cystic carcinoma

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Journal of Clinical Investigation 2019 cited by 210

  14. Hypoxia-Directed Treatment of Human Papillomavirus–Related Oropharyngeal Carcinoma

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , James Fetten, Anuja Kripani, David G. Pfister, Alan L. Ho, Amita Shukla‐Dave, John L. Humm, Simon N. Powell, Bob T. Li, Jorge S. Reis‐Filho, Luis A. Díaz, Richard J. Wong, Nadeem Riaz - Journal of Clinical Oncology 2024 cited by 93

  15. American Head and Neck Society Endocrine Surgery Section and International Thyroid Oncology Group consensus statement on mutational testing in thyroid cancer: Defining advanced thyroid cancer and its targeted treatment

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Gregory W. Randolph - Head & Neck 2022 cited by 113

  16. SWI/SNF Complex Mutations Promote Thyroid Tumor Progression and Insensitivity to Redifferentiation Therapies

    Authors: , , , , , , , , , , , , , , , , , - Cancer Discovery 2020 cited by 109

  17. Consensuses, controversies, and future directions in treatment deintensification for human papillomavirus‐associated oropharyngeal cancer

    Authors: , , , , , , , , , , , , , , , , , , , - CA A Cancer Journal for Clinicians 2022 cited by 57

  18. Precision Radiotherapy: Reduction in Radiation for Oropharyngeal Cancer in the 30 ROC Trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Eric J. Moore, Joaquín J. García, Robert L. Foote, Alan L. Ho, Richard J. Wong, Timothy A. Chan, Simon N. Powell, Paul C. Boutros, John L. Humm, Amita Shukla‐Dave, David G. Pfister, Jorge S. Reis‐Filho, Nancy Y. Lee - JNCI Journal of the National Cancer Institute 2020 cited by 160

  19. NCCN Guidelines® Insights: Squamous Cell Skin Cancer, Version 1.2022

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Valencia D. Thomas, Yaohui Xu, Beth McCullough, Mary A. Dwyer, Mai Q. Nguyen - Journal of the National Comprehensive Cancer Network 2021 cited by 144

  20. Subtype-specific genomic alterations define new targets for soft-tissue sarcoma therapy

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Agnès Viale, Wendy Winckler, Robert G. Maki, Levi A. Garraway, Alex Lash, Heidi Greulich, David E. Root, William R. Sellers, Gary K. Schwartz, Cristina R. Antonescu, Eric S. Lander, Harold Varmus, Marc Ladanyi, Chris Sander, Matthew Meyerson, Samuel Singer - Nature Genetics 2010 cited by 726

  21. Systemic therapy in the management of metastatic or locally recurrent adenoid cystic carcinoma of the salivary glands: a systematic review

    Authors: , , , , - The Lancet Oncology 2010 cited by 395

  22. Selumetinib Plus Adjuvant Radioactive Iodine in Patients With High-Risk Differentiated Thyroid Cancer: A Phase III, Randomized, Placebo-Controlled Trial (ASTRA)

    Authors: , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2022 cited by 63

  23. Basal Cell Skin Cancer, Version 2.2024, NCCN Clinical Practice Guidelines in Oncology

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Puja Venkat, Yaohui Xu, Siegrid S. Yu, Mehran Yusuf, Beth McCullough, Sara Espinosa - Journal of the National Comprehensive Cancer Network 2023 cited by 117

  24. Evaluation of Proton Therapy Reirradiation for Patients With Recurrent Head and Neck Squamous Cell Carcinoma

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Ian Ganly, Marc A. Cohen, Nancy Y. Lee - JAMA Network Open 2023 cited by 47